Priority Date: 20.02.08 (US 20080030148)

NOVEL COMPOUNDS AND METHODS FOR THERAPY

  • Application ID: EP09712645
  • Status: No opposition filed within time limit

Applicant

Technology company logo small
Technology Company

Attorneys

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting
Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Carpmaels & Ransford LLP and Reitstötter Kinzebach & Partner GbR are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.02.2008 - Priority Date (US 20080030148)
  • 27.08.2009 - Publication A2 (WO2009105513)
  • 03.11.2010 - Publication A2 (EP2245037)
  • 18.06.2014 - Publication B1 (EP2245037)

IPC Classification